Lysophosphatidic acid receptor 1 suppression sensitizes rheumatoid fibroblast-like synoviocytes to tumor necrosis factor-induced apoptosis

Arthritis and Rheumatism

Volumn 64, Issue 8, 2012, Pages 2460-2470

  Orosa, Beatriz ^a   González, Antonio ^a   Mera, Antonio ^a   Gõmez Reino, Juan J ^a   Conde, Carmen ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 7; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTOR 1; LYSOPHOSPHATIDIC ACID RECEPTOR 2; LYSOPHOSPHATIDIC ACID RECEPTOR 3; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; ASSAY; CELL PROLIFERATION; CELL STIMULATION; CELL VIABILITY; CLINICAL ARTICLE; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; FIBROBLAST LIKE SYNOVIOCYTE; GENE IDENTIFICATION; HUMAN; HUMAN CELL; NUCLEOSOME; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; UPREGULATION; WESTERN BLOTTING;

APOPTOSIS; ARTHRITIS, RHEUMATOID; CELL PROLIFERATION; CELLS, CULTURED; CYTOSKELETAL PROTEINS; GENE EXPRESSION REGULATION; HUMANS; OSTEOARTHRITIS; RECEPTORS, LYSOPHOSPHATIDIC ACID; RNA, SMALL INTERFERING; SYNOVIAL MEMBRANE; TNF RECEPTOR-ASSOCIATED DEATH DOMAIN PROTEIN; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84864425616     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.34443     Document Type: Article

References (49)

1. Firestein GS,. Evolving concepts in rheumatoid arthritis. Nature 2003; 423: 356-61.
2. Huber LC, Distler O, Tarner I, Gay RE, Gay S, Pap T,. Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology (Oxford) 2006; 45: 669-75.
3. Pope RM,. Apoptosis as a therapeutic tool in rheumatoid arthritis. Nature Rev Immunol 2002; 2: 527-35.
4. Nakajima T, Aono H, Hasunuma T, Yamamoto K, Shirai T, Kirohata K, et al. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum 1995; 38: 485-91.
5. Asahara H, Hasunuma T, Kobata T, Inoue H, Muller-Ladner U, Gay S, et al. Expression of Fas antigen and Fas ligand in the rheumatoid synovial tissue. J Rheumatol 1997; 24: 430-5.
6. Aggarwal BB,. Signaling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 2003; 3: 745-56.
7. Smeets TJ, Kraan MC, van Loon ME, Tak PP,. Tumor necrosis factor α blockade reduces the synovial cell infiltrate early after initiation of treatment, but apparently not by induction of apoptosis in synovial tissue. Arthritis Rheum 2003; 48: 2155-62.
8. Umezu-Goto M, Tanyi J, Lahad J, Liu S, Yu S, Lapushin R, et al. Lysophosphatidic acid production and action: validated targets in cancer? [published erratum appears in J Cell Biochem 2004;93:427]. J Cell Biochem 2004; 92: 1115-40.
9. Noguchi K, Ishii S, Shimizu T,. Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J Biol Chem 2003; 278: 25600-6.
10. 5. J Biol Chem 2006; 281: 23589-97.
11. Van Meeteren LA, Moolenaar WH,. Regulation and biological activities of the autotoxin-LPA axis. Prog Lipid Res 2007; 46: 145-60.
12. Santos AN, Riemann D, Santos AN, Kehlen A, Thiele K, Langner J,. Treatment of fibroblast-like synoviocytes with IFN-γ results in the down-regulation of autotaxin mRNA. Biochem Biophys Res Commun 1996; 229: 419-24.
13. Kehlen A, Lauterbach R, Santos AN, Thiele K, Kabisch U, Weber E, et al. IL-1β- and IL-4-induced downregulation of autotaxin mRNA and PC-1 in fibroblast-like synoviocytes of patients with rheumatoid arthritis (RA). Clin Exp Immunol 2001; 123: 147-54.
14. Zhao C, Fernandes MJ, Prestwich GD, Turgeon M, Battista JD, Clair T, et al. Regulation of lysophosphatidic acid receptor expression and function in human synoviocytes: implications for rheumatoid arthritis? Mol Pharmacol 2007; 73: 587-600.
15. Nochi H, Tomura H, Tobo M, Tanaka N, Sato K, Shinozaki T, et al. Stimulatory role of lysophosphatidic acid in cyclooxygenase-2 induction by synovial fluid of patients with rheumatoid arthritis in fibroblast-like synovial cells. J Immunol 2008; 181: 5111-9.
16. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
17. Nagasaki T, Gundersen GG,. Depletion of lysophosphatidic acid triggers a loss of oriented detyrosinated microtubules in motile fibroblasts. J Cell Sci 1996; 109: 2461-9.
18. Garcia S, Liz M, Gomez-Reino JJ, Conde C,. Akt activity protects rheumatoid synovial fibroblasts from Fas-induced apoptosis by inhibition of Bid cleavage. Arthritis Res Ther 2010; 12: R33.
19. Gerritsen ME, Shen CP, Perry CA,. Synovial fibroblasts and the sphingomyelinase pathway: sphingomyelin turnover and ceramide generation are not signaling mechanisms for the actions of tumor necrosis factor-α. Am J Pathol 1998; 152: 505-2.
20. Connor AM, Berger S, Narendran A, Keystone EC,. Inhibition of protein geranylgeranylation induces apoptosis in synovial fibroblasts. Arthritis Res Ther 2006; 8: R94.
21. Radeff-Huang J, Seasholtz TM, Matteo RG, Brown JH,. G protein mediated signaling pathways in lysophospholipid induced cell proliferation and survival. J Cell Biochem 2004; 92: 949-66.
22. Ramachandran S, Shida D, Nagahashi M, Fang X, Milstien S, Takabe K, et al. Lysophosphatidic acid stimulates gastric cancer cell proliferation via ERK1-dependent upregulation of sphingosine kinase 1 transcription. FEBS Lett 2010; 584: 4077-82.
23. Panupinthu N, Lee HY, Mills GB,. Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progression. Br J Cancer 2010; 102: 941-6.
24. Hurst JH, Hooks SB,. Lysophosphatidic acid stimulates growth by different mechanisms in SKOV-3 and Caov-3 ovarian cancer cells: distinct roles for Gi- and Rho-dependent pathways. Pharmacology 2009; 83: 333-47.
25. Tigyi G, Dyer DL, Miledi R,. Lysophosphatidic acid possesses dual action in cell proliferation. Proc Natl Acad Sci U S A 1994; 91: 1908-12.
26. Choi JW, Lee CW, Chun J,. Biological roles of lysophospholipid receptors revealed by genetic null mice: an update. Biochim Biophys Acta 2008; 1781: 531-9.
27. Lee SJ, Yun CC,. Colorectal cancer cells: proliferation, survival and invasion by lysophosphatidic acid. Int J Biochem Cell Biol 2010; 42: 1907-10.
28. Youn J, Kim HY, Park JH, Hwang SH, Lee SY, Cho CS, et al. Regulation of TNFα-mediated hyperplasia through TNF receptors, TRAGs, and NFκB in synoviocytes obtained from patients with rheumatoid arthritis. Immunol Lett 2002; 83: 85-93.
29. Lacey D, Sampey A, Mitchell R, Bucala R, Santos L, Leech M, et al. Control of fibroblast-like synoviocyte proliferation by macrophage migration inhibitory factor. Arthritis Rheum 2003; 48: 103-9.
30. Okazaki Y, Sawada T, Nagatani K, Komagata Y, Inoue T, Muto S, et al. Effect of nuclear factor-κB inhibition on rheumatoid fibroblast-like synoviocytes and collagen induced arthritis. J Rheumatol 2005; 32: 1440-7.
31. Garcia S, Bodano A, Pablos JL, Gomez-Reino JJ, Conde C,. Poly(ADP-ribose) polymerase inhibition reduces tumor necrosis factor-induced inflammatory response in rheumatoid synovial fibroblasts. Ann Rheum Dis 2008; 67: 631-7.
32. Baier A, Meineckel I, Gay S, Pap T,. Apoptosis in rheumatoid arthritis. Curr Opin Rheumatol 2003; 15: 274-9.
33. Korb A, Pavenstadt H, Pap T,. Cell death in rheumatoid arthritis. Apoptosis 2009; 14: 447-54.
34. Abreu J, de Launay D, Sanders ME, Grabiec AM, van de Sande MG, Tak PP, et al. The Ras guanine nucleotide exchange factor RasGRF1 promotes matrix metalloproteinase-3 production in rheumatoid arthritis synovial tissue. Arthritis Res Ther 2009; 11: R121.
35. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995; 3: 673-82.
36. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A,. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 1996; 271: 12687-90.
37. Dharmapatni A, Smith MD, Findlay DM, Holding CA, Evdokiou A, Ahern MJ, et al. Elevated expression of caspase-3 inhibitors, survivin and xIAP correlates with low levels of apoptosis in active rheumatoid synovium. Arthritis Res Ther 2009; 11: R13.
38. Ichikawa K, Liu W, Fleck M, Zhang H, Zhao L, Ohtsuka T, et al. TRAIL-R2 (DR5) mediates apoptosis of synovial fibroblasts in rheumatoid arthritis. J Immunol 2003; 171: 1061-9.
39. Yao Q, Seol DW, Mi Z, Robbins PD,. Intra-articular injection of recombinant TRAIL induces synovial apoptosis and reduces inflammation in a rabbit knee model of arthritis. Arthritis Res Ther 2006; 8: R16.
40. Song K, Chen Y, Goke R, Wilmen A, Seidel C, Goke A, et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression. J Exp Med 2000; 191: 1095-103.
41. Hsu H, Xiong J, Goeddel DV,. The TNF receptor-1 associated protein TRADD signals cell death and NF-κB activation. Cell 1995; 81: 495-504.
42. Micheau O, Tschopp J,. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003; 114: 181-90.
43. Ermoleva MA, Michallet MC, Papadopoulou N, Utermohlen O, Kranidioti K, Kollias G, et al. Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses. Nat Immunol 2008; 9: 1037-46.
44. McConnell BB, Vertino PM,. Activation of a caspase-9-mediated apoptotic pathway by subcellular redistribution of the novel caspase recruitment domain protein TMS1. Cancer Res 2000; 60: 6243-7.
45. Masumoto J, Taniguchi S, Nakayama J, Shiohara M, Hidaka E, Katsuyama T, et al. ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL-60 cells. J Biol Chem 1999; 274: 18980-9.
46. Srinivasula SM, Poyet JL, Razmara M, Datta P, Zhang Z, Alnemri ES,. The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J Biol Chem 2002; 277: 21119-22.
47. Ellebedy AH, Lupfer C, Ghoneim HE, DeBeauchamp J, Kanneganti TD, Webby RJ,. Inflammasome-independent role of the apoptosis-associated speck-like protein containing CARD (ASC) in the adjuvant effect of MF59. Proc Natl Acad Sci U S A 2011; 108: 2927-32.
48. Franchi L, Munoz-Planillo R, Reimer T, Eigenbrod T, Nunez G,. Inflammasomes as microbial sensors. Eur J Immunol 2010; 40: 611-5.
49. Masumoto J, Dowds TA, Schaner P, Chen FF, Ogura Y, Li M, et al. ASC is an activating adaptor for NF-κB and caspase-8-dependent apoptosis. Biochem Biophys Res Commun 2003; 303: 69-73.